Evidence map›Paper›PMID 34850833›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Good Financial Grant Practice: A Tool for Developing and Demonstrating Institutional Financial and Grant Management Capacity in Global Health.

Harry J Harste, Genevieve Kiff, Iruka N Okeke, Akindele O Adebiyi, K L Ravikumar, Geetha Nagaraj, Jolaade J Ajiboye, Erik C D Osma Castro, Elmer Herrera, David M Aanensen and 1 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Implementing Whole-Genome Sequencing for Ongoing Surveillance of Antimicrobial Resistance: Exemplifying Insights Into Klebsiella pneumoniae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Harry J HarsteOxford Big Data Institute, University of Oxford, Oxford, United Kingdom; Wellcome Genome Campus, Hinxton, United Kingdom.
Genevieve KiffOxford University Clinical Research Unit, Hanoi, Vietnam; African Academy of Sciences, Nairobi, Kenya.
Iruka N OkekeDepartment of Pharmaceutical Microbiology, University of Ibadan, Ibadan, Nigeria.
Akindele O AdebiyiCollege Research and Innovation Management, College of Medicine, University of Ibadan, Nigeria.
K L RavikumarCentral Research Laboratory, Kempegowda Institute of Medical Sciences, Bengaluru, India.
Geetha NagarajCentral Research Laboratory, Kempegowda Institute of Medical Sciences, Bengaluru, India.
Jolaade J AjiboyeDepartment of Pharmaceutical Microbiology, University of Ibadan, Ibadan, Nigeria.
Erik C D Osma CastroAGROSAVIA (Corporación Colombiana de Investigación Agropecuaria), Bogotá, Colombia.
Elmer HerreraAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute of Tropical Medicine, Manila, Philippines.
David M AanensenOxford Big Data Institute, University of Oxford, Oxford, United Kingdom; Wellcome Genome Campus, Hinxton, United Kingdom.
NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance

Funding

Medical Research Council MR/L00464X/1National Institute for Health Research 16_136_111Wellcome Trust 206194
6 · The paper itself

Abstract

The administration and governance of grant funding across global health organizations presents enormous challenges. Meeting these challenges is crucial to ensuring that funds are used in the most effective way to improve health outcomes, in line with the United Nations' Sustainable Development Goal 3, "Ensure healthy lives and promote well-being for all at all ages." The Good Financial Grant Practice (GFGP) Standard (ARS 1651) is the world's first and, currently, only international standard for the financial governance and management of grant funding. Through consensus building and global harmonization between both low- and middle-income and high-income country players, the GFGP Standard has achieved a leveling impact: GFGP applies equally to, and can be implemented by, all types of organization, regardless of location, size, or whether they predominantly give or receive funding. GFGP can be used as a tool for addressing some of the challenges of the current funding model. Here, we describe our experiences and lessons learned from implementing GFGP across 4 diverse research institutions in India, Nigeria, Colombia, and the Philippines as part of our National Institute for Health Research Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance.

Indexed as

Financing, OrganizedGlobal HealthHumansIncomeIndiaNigeriaGFGPGood Financial Grant Practicegovernancegrant managementresearch funding

Identifiers

PMID34850833
PMCPMC8634540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.